Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs

NCT07119242 is registered in ClinicalTrials.gov with HTA Co., Ltd. as lead sponsor.

NCT NCT07119242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07119242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs
Lead sponsor
HTA Co., Ltd.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 8, 2024
Completion date
December 31, 2025
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nets